Cassinari V, Pagni CA: Central Pain: A Neurosurgical Survey. Cambridge, MA: Harvard University Press, 1969.
3.
Leijon G, Boivie J, Johansson I: Central post-stroke pain—neurological symptoms and pain characteristics. Pain. 1989; 36: 13-25.
4.
Andersen G, Vestergaard K, Ingeman-Nielsen M, Jensen TS: Incidence of central post-stroke pain. Pain. 1995; 61: 187-194.
5.
Garcin R: La douleur dans les affections organiques du système nerveux central. Rev Neurol. 1937; 69: 105-153.
6.
Vestergaard K, Nielsen J, Andersen G, et al.: Sensory abnormalities in consecutive, unselected patients with central post-stroke pain. Pain. 1995; 61: 177-186.
7.
Bowsher D: Central pain: Clinical and physiological characteristics. J Neurol Neurosurg Psychiat. 1996; 61: 62-69.
8.
Bowsher D: Central Pain. Pain Rev. 1995; 2: 175-186.
9.
Nurmikko T, Wells C, Bowsher D: Pain and allodynia in postherpetic neuralgia: Role of somatic and sympathetic systems. Acta Neurol Scand. 1991; 84: 146-152.
10.
Baron R, Saguer M: Mechanical allodynia in postherpetic neuralgia: Evidence for central mechanisms depending on nociceptive C-fiber degeneration. Neurol. 1995; 45Suppl 8: 63-65.
11.
Leijon G, Boivie J: Central post-stroke pain - A controlled trial of amitriptyline and carbamazepine. Pain. 1989; 36: 27-36.
12.
McQuay H, Carroll D, Jadad AR, et al.: Anticonvulsant drugs for the management of pain: A systematic review. Brit Med J. 1995; 31: 1047-1052.
13.
Nurmikko T: personal communication.
14.
Ardid D, Guilbaud G: Antinociceptive effects of acute and “chronic” injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats. Pain. 1992; 49: 279-287.
15.
Koppel BS: Amitriptyline in the treatment of thalamic pain. Southern Med J. 1982; 79: 759-761.
16.
Watson CPN, Vernich L, Chipman M, Reed K: Nortriptyline versus amitriptyline in postherpetic neuralgia: A randomized trial. Neurol. 1998; 51: 1166-1171.
17.
Leijon G, Boivie J: Pharmacological treatment of central pain. In Casey KL (ed.): Pain and Central Nervous System Disease: The Central Pain Syndromes. New York: Raven Press, 1991; 257-266.
18.
Bowsher D: The management of central post-stroke pain. Postgrad Med J. 1995b; 71: 598-604.
Awerbuch GI, Sandyk R: Mexiletine for thalamic pain syndrome. Int J Neurosci. 1990; 55: 129-133.
22.
Ebert B, Andersen S, Krogaard-Larsen P: Ketobemidone, methadone and pethidine are non-competitive N-methyl D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett. 1995; 187: 165-168.
23.
Gorman AI, Elliott KJ, Inturrisi CE: The D- and L-isomers of methadone bind to the non-competitive site on the NMDA receptor in rat forebrain and spinal cord. Neurosci Lett. 1997; 223: 5-8.
24.
Codd EE, Shank RP, Schupsky JJ, Raffa RB: Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: Structural determinants and role in antinociception. J Pharamcol Exp Ther. 1995; 274: 1263-1270.
25.
Eide PK, Stubhaug A, Oye I, Breivik H: Continuous subcutaneous administration of the N-methyl D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain. 1995; 61: 221-228.
26.
Takahashi H, Miyazaki M, Nanbu T, et al.: The NMDA-receptor antagonist ketamine abolishes neuropathic pain after epidural administration in a clinical case. Pain. 1998; 75: 391-394.
27.
Morley JS, Makin MK: The use of methadone in cancer pain poorly responsive to other opioids. Pain Rev. 1998; 5: 51-58.
28.
Makin MK, O’Donnell V, Skinner JM, Ellershaw JE: Methadone in the management of cancer-related neuropathic pain. Pain Clin. 1998; 10: 275-279.
29.
Lipton S: Percutaneous cordotomy. In Wall PD, Melzack R (eds.): Textbook of Pain. London: Churchill Livingstone, 1984: 632-638.
30.
Miles J: Electrical stimulation for the relief of pain. Ann Roy Coll Surg Eng. 1984; 66: 108-112.
